CN110013244A - Medical cardiac bioelectricity monitoring device and its monitoring method - Google Patents
Medical cardiac bioelectricity monitoring device and its monitoring method Download PDFInfo
- Publication number
- CN110013244A CN110013244A CN201910311929.9A CN201910311929A CN110013244A CN 110013244 A CN110013244 A CN 110013244A CN 201910311929 A CN201910311929 A CN 201910311929A CN 110013244 A CN110013244 A CN 110013244A
- Authority
- CN
- China
- Prior art keywords
- module
- optical fibre
- signal
- interferometric sensor
- real
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
Abstract
The invention belongs to medical monitoring arts fields, in particular to a kind of monitoring method of medical cardiac bioelectricity monitoring device.Including optical fibre interferometric sensor module, identification module, algoritic module and real-time display module；The input terminal of the output end connection identification module of optical fibre interferometric sensor module, the output end of the input terminal of the output end join algorithm module of identification module, algoritic module connect real-time display module；Real-time display module is connect with optical fibre interferometric sensor module.There is inconvenient long term monitoring to improve existing cardiac monitoring equipment in the present invention.Applied to monitor center equipment, the monitor center equipment and acquisition equipment communication connection.
Description
Technical field
The invention belongs to medical monitoring arts fields, in particular to a kind of monitoring side of medical cardiac bioelectricity monitoring device
Method.
Background technique
Cardiovascular and cerebrovascular disease is exactly that cardiovascular and cerebrovascular disease are referred to as.Cardiovascular and cerebrovascular disease is that one kind seriously threatens
The mankind, the common disease of especially 50 years old or more middle-aged and the old's health.Even if application treatment means most advanced, perfect at present, still
Can have 50% or more cerebrovascular accident survivor life cannot take care of oneself completely.The people of cardiovascular and cerebrovascular disease is died of in the whole world every year
Number is up to 15,000,000 people, and it is the first to occupy the various causes of the death.Cardiovascular and cerebrovascular disease has become the highest number one killer of human death's cause of disease.
Coronary heart disease is one kind by organic (the atherosclerosis or dynamic property vasopasm) stenosis or occlusion of coronary artery
The heart disease of caused myocardial ischemia-anoxemia (angina pectoris) or myocardial necrosis (myocardial infarction), also known as ischemic heart disease.Coronary disease
Disease has become one of the disease for threatening human health most serious, is the underlying cause of death in the U.S. and certain industrialized countries.Coronary heart disease
Global public hazards are had become, American wins heart trouble as " pestilence in epoch ".
Myocardial infarction is the ischemic necrosis of cardiac muscle.For coronary artery blood supply occurs on the basis of coronary artery pathological changes
It sharply reduces or interrupts, make corresponding cardiac muscle seriously and enduringly caused by acute ischemia.Clinical manifestation has play after lasting breastbone
Strong pain, fever, white blood cell count(WBC) and Serum fibrosis markers increase and electrocardiogram is sexually revised；Arrhythmia cordis can occur, stop
Gram or heart failure, belong to the serious types of coronary heart disease
Analysis of heart rate variability is a kind of method for measuring successive heartbeat rate variation degree.Rhythmical discharge activiy of the heart in addition to itself
Except the bounce of initiation, also regulated and controled by autobnomic nervous system.Analysis of heart rate variability is also found to can be used as the prediction generation heart
The index of the death rate after muscle infarction and the prognosis for predicting latter stage liver cancer sufferer.It can be seen that the prevention of cardiovascular disease and examining
It is disconnected to have great importance.And the problem of existing cardiac monitoring equipment generally existing inconvenient long term monitoring.
Summary of the invention
It is an object of that present invention to provide a kind of monitoring methods of medical cardiac bioelectricity monitoring device, to improve existing electrocardio prison
All there is inconvenient long term monitoring in shield equipment.Applied to monitor center equipment, the monitor center equipment is set with acquisition
Standby communication connection.
To achieve the above object, the present invention adopts the following technical scheme:
A kind of medical treatment cardiac bioelectricity monitoring device, including optical fibre interferometric sensor module, identification module, algoritic module and aobvious in real time
Show module；
The input terminal of the output end connection identification module of optical fibre interferometric sensor module, the output end of identification module connect
The input terminal of algoritic module is connect, the output end of algoritic module connects real-time display module；
Real-time display module is connect with optical fibre interferometric sensor module.
Further, the optical fibre interferometric sensor module is dry using fiber optic interferometric demodulator, single mode optical fiber and optical fiber
Relate to sensor；
Optical fibre interferometric sensor module is connect by single mode optical fiber with optical fibre interferometric sensor；
Optical fibre interferometric sensor module is used to acquire the ballistocardiography signal of guardianship.
Further, the optical fibre interferometric sensor is Michelson fiber optic sensor, Mach once moral fibre optical sensor
Or one of SAGNAC fibre optical sensor.
A kind of monitoring method of medical treatment cardiac bioelectricity monitoring device, method and step are as follows:
A, optical fibre interferometric sensor carries out ballistocardiography signal acquisition to guardianship；
B, identification signals are obtained according to collected ballistocardiography signal to compare and save with database；
C, collected ballistocardiography signal is compared with database, judges whether signal is abnormal, is to issue police
It reports and shows on the display device；
In step B: the identification module obtains one using the ballistocardiography signal that optical fibre interferometric sensor module obtains
The bio-identification signal is compared and is saved with database by bio-identification signal；
In step C: collected ballistocardiography signal is compared algoritic module with database, judges whether signal is different
It often, is to sound an alarm;
In step C: real-time display module is used for the result of real-time display algorithm module judgement.
Beneficial effects of the present invention:
Medical monitoring device provided by the invention, the active signal of energy long term monitoring heart, can be according to ballistocardiography signal to prison
It protects object and carries out identification, and collected ballistocardiography signal is compared with database, whether judge signal
It is abnormal, it is to sound an alarm.
The present invention can carry out real-time display to collected ballistocardiography signal, improve the real-time of medical monitoring.
Acquisition device energy of the present invention is noninvasive, non-skin directly contact carries out ballistocardiography signal to guardianship and adopts
Collection, improves the sensitivity of acquisition.
The present invention obtains the identity information of guardianship according to ballistocardiography signal, can accurately be supervised to guardianship
Shield, further increases the efficiency and reliability of medical monitoring.
Detailed description of the invention
Fig. 1 is the structural block diagram of medical treatment cardiac bioelectricity monitoring device provided by the embodiment of the present invention；
Fig. 2 is a kind of structural schematic diagram of optical fibre interferometric sensor provided by the embodiment of the present invention；
Fig. 3 is Mach-Zehnder fibre optical sensor schematic diagram provided by the embodiment of the present invention；Fig. 4 is institute of the embodiment of the present invention
The Michelson fiber optic sensor schematic diagram of offer；
Fig. 5 is SAGNAC fibre optical sensor schematic diagram provided by the embodiment of the present invention；
Fig. 6 is the flow chart of monitoring method provided by the embodiment of the present invention.
Specific embodiment
Below in conjunction with attached drawing, the invention will be further described.
Embodiment one
The present embodiment one is a kind of medical cardiac bioelectricity monitoring device, as shown in Figure 1, Fig. 1 is shown provided by the embodiment of the present invention
A kind of medical treatment cardiac bioelectricity monitoring device, including optical fibre interferometric sensor module 101, identification module 102,103 and of algoritic module
Real-time display module 104；
The input terminal of the output end connection identification module 102 of optical fibre interferometric sensor module 101, identification module 102
Output end join algorithm module 103 input terminal, the output end of algoritic module 103 connects real-time display module 104；
Real-time display module 104 is connect with optical fibre interferometric sensor module 101.
Referring to Fig. 2, the optical fibre interferometric sensor module 101 uses fiber optic interferometric demodulator 201, single mode optical fiber 202
With optical fibre interferometric sensor 203；
Optical fibre interferometric sensor module 101 is connect by single mode optical fiber 202 with optical fibre interferometric sensor 203；
Optical fibre interferometric sensor module 203 is used to acquire the ballistocardiography signal of guardianship.
Optical fibre interferometric sensor 203 described in the present embodiment is Mach once moral fibre optical sensor 2031.
Once moral fibre optical sensor 2031 is fibre optic interferometer to the Mach, and optical signal is propagated in two optical fiber respectively,
Two optical fiber one is pickup arm 20311, and one is reference arm 20312.
The identification module 102 is obtained using the ballistocardiography signal that optical fibre interferometric sensor module 101 obtains
One biological identification signal, the bio-identification signal is compared and is saved with database.
Collected ballistocardiography signal is compared the algoritic module 103 with database, judges signal
It is whether abnormal, it is to sound an alarm.
The real-time display module 104 is used for the result of real-time display algorithm module judgement.
The fiber optic interferometric demodulator 201 carries out precise measurement to optical fiber interference signal.
The single mode optical fiber 202 is common single mode optical fiber.
The basic functional principle of optical fibre interferometric sensor is as follows in the present embodiment:
Optical fibre interferometric sensor described in the present embodiment is Mach-Zehnder fibre optical sensor, when light passing in sensor, because of people
The body movement signal of body acts on the pickup arm of sensor, causes the light path difference of two-beam that can generate fixed skew to generate
Interference effect.In Mach-Zehnder fibre optical sensor, pickup arm is used to measure the variable quantity of external environment, locating for pickup arm
The variation physical quantity of environment can cause the phase of two beam interferometer light to change to change so as to cause interference spectrum.Interference light
Human body ballistocardiography signal has been reacted in the change of spectrum, and the mesh to ballistocardiography signal acquisition is realized by the detection to interference spectrum
's.
Embodiment two
The present embodiment two is a kind of monitoring method of medical cardiac bioelectricity monitoring device, and referring to Fig. 6, its method and step is characterized in that:
A, optical fibre interferometric sensor carries out ballistocardiography signal acquisition 301 to guardianship；
B, identification signals are obtained according to collected ballistocardiography signal and database compares and saves 302；
C, collected ballistocardiography signal is compared with database, judges whether signal is abnormal, is to issue police
It reports and shows 303 on the display device；
In step A: the optical fibre interferometric sensor includes Mach-Zehnder fibre optical sensor 2031, Michelson optical fiber biography
Sensor 2032 or SAGNAC fibre optical sensor 2033, can be one such in the particular embodiment.
In step A: the ballistocardiography signal acquisition refers to the dynamic letter of body for acquiring human body using fibre optical sensor 203
Number.
In step B: the ballistocardiography that the identification module 102 is obtained using optical fibre interferometric sensor module 101
Signal obtains a biological identification signal, and the bio-identification signal is compared and saved with database；
In step C: collected ballistocardiography signal is compared algoritic module 103 with database, judges that signal is
No exception is to sound an alarm;
In step C: real-time display module 104 is used for the result of real-time display algorithm module judgement.
Description and application of the invention herein are illustrative, not limits the scope of the invention to above-described embodiment
In.The modification and improvement of embodiments disclosed herein are possible, embodiments for those of ordinary skill in the art
The equivalent various parts of replacement be well known.It without departing from the spirit or essential characteristics of the invention, can be right
Embodiments disclosed herein carries out other deformations and changes.
Claims (4)
1. a kind of medical treatment cardiac bioelectricity monitoring device, it is characterised in that: including optical fibre interferometric sensor module (101), identification mould
Block (102), algoritic module (103) and real-time display module (104)；
The input terminal of output end connection identification module (102) of optical fibre interferometric sensor module (101), identification module
(102) output end of the input terminal of output end join algorithm module (103), algoritic module (103) connects real-time display module
(104)；
Real-time display module (104) is connect with optical fibre interferometric sensor module (101).
2. medical treatment cardiac bioelectricity monitoring device according to claim 1, it is characterised in that: the optical fibre interferometric sensor module
(101) using fiber optic interferometric demodulator (201), single mode optical fiber (202) and optical fibre interferometric sensor (203)；
Optical fibre interferometric sensor module (101) is connect by single mode optical fiber (202) with optical fibre interferometric sensor (203)；
Optical fibre interferometric sensor module (203) is used to acquire the ballistocardiography signal of guardianship.
3. medical treatment cardiac bioelectricity monitoring device according to claim 2, it is characterised in that: the optical fibre interferometric sensor
It (203) is Michelson fiber optic sensor, Mach is once in moral fibre optical sensor or FP fibre optical sensor, SAGNAC fibre optical sensor
One kind.
4. the monitoring method of medical cardiac bioelectricity monitoring device according to claim 1 to 3, the spy of method and step
Sign is:
A, optical fibre interferometric sensor carries out ballistocardiography signal acquisition (301) to guardianship；
B, identification signals are obtained according to collected ballistocardiography signal and database compares and saves (302)；
C, collected ballistocardiography signal is compared with database, judges whether signal is abnormal, is to issue police
It reports and shows (303) on the display device；
In step B: the ballistocardiography that the identification module (102) uses optical fibre interferometric sensor module (101) to obtain
Signal obtains a biological identification signal, and the bio-identification signal is compared and saved with database；
In step C: collected ballistocardiography signal is compared algoritic module (103) with database, judges signal
It is whether abnormal, it is to sound an alarm;
In step C: real-time display module (104) is used for the result of real-time display algorithm module judgement.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910311929.9A CN110013244A (en) | 2019-04-18 | 2019-04-18 | Medical cardiac bioelectricity monitoring device and its monitoring method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910311929.9A CN110013244A (en) | 2019-04-18 | 2019-04-18 | Medical cardiac bioelectricity monitoring device and its monitoring method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110013244A true CN110013244A (en) | 2019-07-16 |
Family
ID=67191766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910311929.9A Pending CN110013244A (en) | 2019-04-18 | 2019-04-18 | Medical cardiac bioelectricity monitoring device and its monitoring method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110013244A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113764095A (en) * | 2020-06-02 | 2021-12-07 | 华为技术有限公司 | User health management and control method and electronic equipment |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN206342462U (en) * | 2016-10-19 | 2017-07-21 | 苏州安莱光电科技有限公司 | A kind of optical fiber vital sign supervising device based on Mach-Zahnder interference |
| US20170215735A1 (en) * | 2014-09-30 | 2017-08-03 | Shenzhen Darma Technology Co., Ltd. | Vital signs fiber optic sensor systems and methods |
| CN107307861A (en) * | 2017-06-02 | 2017-11-03 | 杭州创培信息科技有限公司 | A kind of real-time heart rate monitoring unit of wearable optical fiber |
| CN108304822A (en) * | 2018-02-23 | 2018-07-20 | 余海波 | Signal processing apparatus and method |
| CN108652635A (en) * | 2018-03-27 | 2018-10-16 | 余海波 | medical monitoring device, method and system |
-
2019
- 2019-04-18 CN CN201910311929.9A patent/CN110013244A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170215735A1 (en) * | 2014-09-30 | 2017-08-03 | Shenzhen Darma Technology Co., Ltd. | Vital signs fiber optic sensor systems and methods |
| CN206342462U (en) * | 2016-10-19 | 2017-07-21 | 苏州安莱光电科技有限公司 | A kind of optical fiber vital sign supervising device based on Mach-Zahnder interference |
| CN107307861A (en) * | 2017-06-02 | 2017-11-03 | 杭州创培信息科技有限公司 | A kind of real-time heart rate monitoring unit of wearable optical fiber |
| CN108304822A (en) * | 2018-02-23 | 2018-07-20 | 余海波 | Signal processing apparatus and method |
| CN108652635A (en) * | 2018-03-27 | 2018-10-16 | 余海波 | medical monitoring device, method and system |
Non-Patent Citations (1)
| Title |
|---|
| 韩向可 等: "《传感器原理与应用》", 30 September 2016 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113764095A (en) * | 2020-06-02 | 2021-12-07 | 华为技术有限公司 | User health management and control method and electronic equipment |
| WO2021244186A1 (en) * | 2020-06-02 | 2021-12-09 | 华为技术有限公司 | User health management and control method, and electronic device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pereira et al. | Novel methods for pulse wave velocity measurement | |
| Lin et al. | An intelligent telecardiology system using a wearable and wireless ECG to detect atrial fibrillation | |
| Hwang et al. | Assessing accuracy of wrist-worn wearable devices in measurement of paroxysmal supraventricular tachycardia heart rate | |
| Schlegel et al. | Real-time 12-lead high-frequency QRS electrocardiography for enhanced detection of myocardial ischemia and coronary artery disease | |
| Johnson et al. | R-peak estimation using multimodal lead switching | |
| Tadi et al. | Seismocardiography: Toward heart rate variability (HRV) estimation | |
| Lin et al. | Investigation on cardiovascular risk prediction using physiological parameters | |
| Li et al. | Wearable alignment-free microfiber-based sensor chip for precise vital signs monitoring and cardiovascular assessment | |
| Aydemir et al. | Classification of decompensated heart failure from clinical and home ballistocardiography | |
| JP2017042386A (en) | Biological information processing system and program | |
| Lu et al. | A portable ECG monitor with low power consumption and small size based on AD8232 chip | |
| Reddy et al. | PerDMCS: Weighted fusion of PPG signal features for robust and efficient diabetes mellitus classification | |
| Bonomi et al. | Detecting episodes of brady-and tachycardia using photo-plethysmography at the wrist in free-living conditions | |
| Yi et al. | Piezoelectric approaches for wearable continuous blood pressure monitoring: a review | |
| CN110013244A (en) | Medical cardiac bioelectricity monitoring device and its monitoring method | |
| Trägårdh et al. | Reduced high-frequency QRS components in patients with ischemic heart disease compared to normal subjects | |
| Liu et al. | Cuffless blood pressure measurement using smartwatches: a large-scale validation study | |
| Sondej et al. | Validation of a new device for photoplethysmographic measurement of multi-site arterial pulse wave velocity | |
| Omboni et al. | Ambulatory monitoring of central arterial pressure, wave reflections, and arterial stiffness in patients at cardiovascular risk | |
| Watanabe et al. | Validation of an ambulatory blood pressure monitoring device employing a novel method to detect atrial fibrillation | |
| Kania et al. | High-resolution body surface potential mapping in exercise assessment of ischemic heart disease | |
| Yang et al. | Cuff-less blood pressure measurement using fingertip photoplethysmogram signals and physiological characteristics | |
| Liaqat et al. | A review and comparison of the state-of-the-art techniques for atrial fibrillation detection and skin hydration | |
| Liu et al. | A novel interpretable feature set optimization method in blood pressure estimation using photoplethysmography signals | |
| US9138150B2 (en) | Portable pulseoximeter for a direct and immediate automated evaluation of the cardiac rhythm (regularity) and related method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190716 |
|
| RJ01 | Rejection of invention patent application after publication |